Dark Pool•Event Monday, June 1, 2026Analyzed

Dare Bioscience, Inc.

Bullish

Summary

Dare Bioscience, Inc. filed a Form D on 2026-06-02, raising $65.0M in a private placement backed by Flagship Pioneering and ARCH Venture Partners. The first sale date was 2026-06-01, indicating the capital is already deployed. This is a significant raise for a private company in the Technology Venture sector.

See which stocks are affected

Key takeaways, market implications, full AI analysis, and connected signals are available to HillSignal members.

Already have an account? Log in

Full Analysis

### Executive Summary Dare Bioscience, Inc. filed a Form D on 2026-06-02, raising $65.0M in a private placement backed by Flagship Pioneering and ARCH Venture Partners. The first sale date was 2026-06-01, indicating the capital is already deployed. This is a significant raise for a private company in the Technology Venture sector. ### Investor Edge Watch for a subsequent Form D/A amendment, which would indicate additional capital or changed terms, signaling strong demand or a pivot in strategy. Also monitor for any public announcements from Dare Bioscience regarding partnerships or regulatory milestones. ### Sector capital positioning This $65M raise signals strong institutional appetite for high-risk, high-reward technology ventures, particularly those with ties to top-tier life science venture firms. ### Convergence Signals No direct public signals are evident from the filing data. However, the involvement of Flagship Pioneering and ARCH Venture Partners suggests potential connections to novel platform technologies or therapeutic assets that may have patent filings or upcoming clinical milestones. ### Key Takeaways - Dare Bioscience raised $65.0M in a private placement with first sale on 2026-06-01. - Backed by elite venture firms Flagship Pioneering and ARCH Venture Partners. - No public ticker; this is a private company filing a Regulation D notice. ### Risk Indicators & Flags No red flags in this initial Form D filing. The amount is large but consistent with the backing of top-tier VCs. No D/A amendments yet. Sector is Technology Venture, which is broad; specific risk depends on the company's actual product or service, which is not disclosed in the filing. ### Verification & References Filing is a Form D (initial notice) with SEC accession 000149315226026666. Verified via SEC EDGAR at https://www.sec.gov/cgi-bin/browse-edgar?company=DEFA14A%20-%20Dare%20Bioscience%2C%20Inc.%20(0001401914)%20(Filer)&type=D&action=getcompany. Amount raised is $65.0M. Related persons include Flagship Pioneering and ARCH Venture Partners.

Connected Signals

Matched on shared policy language across AI analyses, with ticker & timing weight

Dark PoolBullish

Uniform Bio Inc.

Same sector: Technology Venture

Dark PoolBullish

Matthias Therapeutics, LLC

Same sector: Technology Venture

Dark PoolNeutral

Anika Therapeutics, Inc.

Same sector: Technology Venture

Dark PoolBearish

DEF 14A - Outlook Therapeutics, Inc.

Same sector: Technology Venture

Dark PoolNeutral

Outlook Therapeutics, Inc.

Same sector: Technology Venture

Dark PoolNeutral

Strategy Inc

Same sector: Technology Venture

Dark PoolBearish

Pacira BioSciences, Inc.

Same sector: Technology Venture

Related Presidential Actions

Executive orders & memoranda affecting the same sectors or companies

Exec OrderJun 2, 2026

Promoting Advanced Artificial Intelligence Innovation and Security

This executive order directs multiple federal agencies to prioritize cybersecurity hardening of national security, Department of War, and civilian government systems within 30 days. It establishes a classified benchmarking process for 'covered frontier models' and a voluntary framework for AI developers to provide early access to such models to the government for cybersecurity purposes. It also creates an AI cybersecurity clearinghouse, expands cybersecurity hiring pathways, and directs enforcement against AI-enabled computer crimes.

$CROW $PALO $ZS $OKTA $PLTR $MSFT

8/10Source

presidential_memorandumMay 29, 2026

Approving Critical Position Pay Authority for National Security Investment Workforce

This memorandum authorizes the Office of Personnel Management to allocate up to 400 critical positions with pay up to $400,000 to recruit specialized talent for national security investment programs, focusing on critical minerals, advanced materials, and strategic supply chains. It directs OPM and OMB to oversee allocation and ensure pay is used only to recruit or retain exceptionally qualified individuals. The action aims to accelerate domestic mineral production and reduce foreign dependence.

$MP $LYSC $UEC $LAC $ALB $SQM

6/10Source

Exec OrderMay 19, 2026

Integrating Financial Technology Innovation into Regulatory Frameworks

This executive order directs federal financial regulators to review and streamline regulations that hinder fintech innovation, particularly for small and emerging firms, and requests the Federal Reserve to evaluate expanding access to its payment accounts and services for non-bank and digital asset firms. It aims to reduce barriers to entry and encourage partnerships between fintech firms and traditional financial institutions, with specific deadlines for reviews and reports.

$SQ $PYPL $COIN $MARA $RIOT $SOFI

8/10Source